Title : The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis.

Pub. Date : 2010 Dec

PMID : 20926154






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here we present an updated meta-analysis of the respective effects of rosiglitazone and pioglitazone on the levels of C-reactive protein (CRP), a biomarker and predictor of CAD risks. Rosiglitazone C-reactive protein Homo sapiens
2 Here we present an updated meta-analysis of the respective effects of rosiglitazone and pioglitazone on the levels of C-reactive protein (CRP), a biomarker and predictor of CAD risks. Rosiglitazone C-reactive protein Homo sapiens
3 CONCLUSIONS: Our meta-analysis suggested that both rosiglitazone and pioglitazone significantly decrease serum CRP levels. Rosiglitazone C-reactive protein Homo sapiens